These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28007354)

  • 1. Gut epithelial barrier markers in patients with obstructive sleep apnea.
    Barceló A; Esquinas C; Robles J; Piérola J; De la Peña M; Aguilar I; Morell-Garcia D; Alonso A; Toledo N; Sánchez-de la Torre M; Barbé F
    Sleep Med; 2016 Oct; 26():12-15. PubMed ID: 28007354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obstructive sleep apnea and liver injury in severely obese patients with nonalcoholic fatty liver disease.
    Zhang L; Zhang X; Meng H; Li Y; Han T; Wang C
    Sleep Breath; 2020 Dec; 24(4):1515-1521. PubMed ID: 32002742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver disease.
    Hendy OM; Elsabaawy MM; Aref MM; Khalaf FM; Oda AMA; El Shazly HM
    APMIS; 2017 Jul; 125(7):607-613. PubMed ID: 28430371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired intestinal barrier in patients with obstructive sleep apnea.
    Li Q; Xu T; Zhong H; Gao W; Shao C; Feng L; Li T
    Sleep Breath; 2021 Jun; 25(2):749-756. PubMed ID: 32845474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between continuous positive airway pressure and serum aminotransferases in patients with obstructive sleep apnea.
    Chen LD; Zhang LJ; Lin XJ; Qi JC; Li H; Wu Z; Xu QZ; Huang YP; Lin L
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):587-594. PubMed ID: 29224042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
    Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
    World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zonulin level, a marker of intestinal permeability, is increased in association with liver enzymes in young adolescents.
    Kim JH; Heo JS; Baek KS; Kim SY; Kim JH; Baek KH; Kim KE; Sheen YH
    Clin Chim Acta; 2018 Jun; 481():218-224. PubMed ID: 29544751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut Permeability Might be Improved by Dietary Fiber in Individuals with Nonalcoholic Fatty Liver Disease (NAFLD) Undergoing Weight Reduction.
    Krawczyk M; Maciejewska D; Ryterska K; Czerwińka-Rogowska M; Jamioł-Milc D; Skonieczna-Żydecka K; Milkiewicz P; Raszeja-Wyszomirska J; Stachowska E
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for liver injury in the setting of obstructive sleep apnea.
    Byrne TJ; Parish JM; Somers V; Aqel BA; Rakela J
    Ann Hepatol; 2012; 11(2):228-31. PubMed ID: 22345340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstructive sleep apnea is associated with fatty liver and abnormal liver enzymes: a meta-analysis.
    Sookoian S; Pirola CJ
    Obes Surg; 2013 Nov; 23(11):1815-25. PubMed ID: 23740153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease is an independent risk factor for inflammation in obstructive sleep apnea syndrome in obese Asian Indians.
    Bhatt SP; Guleria R; Vikram NK; Gupta AK
    Sleep Breath; 2019 Mar; 23(1):171-178. PubMed ID: 30032465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea.
    Norman D; Bardwell WA; Arosemena F; Nelesen R; Mills PJ; Loredo JS; Lavine JE; Dimsdale JE
    Sleep; 2008 Jan; 31(1):121-6. PubMed ID: 18220085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between obstructive sleep apnea and non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Jin S; Jiang S; Hu A
    Sleep Breath; 2018 Sep; 22(3):841-851. PubMed ID: 29335916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obstructive sleep apnea is independently associated with inflammation and insulin resistance, but not with blood pressure, plasma catecholamines, and endothelial function in obese subjects.
    Araújo Lda S; Fernandes JF; Klein MR; Sanjuliani AF
    Nutrition; 2015; 31(11-12):1351-7. PubMed ID: 26429654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of obstructive sleep apnea with continuous positive airway pressure decreases adipocyte fatty acid-binding protein levels.
    Sovova E; Hobzova M; Stejskal D; Sova M; Kolek V; Zapletalova J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Mar; 156(1):58-62. PubMed ID: 22580862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
    Suh JB; Kim SM; Cho GJ; Choi KM
    Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and obstructive sleep apnea syndrome.
    Acıoğlu E; Yiğit O; Volkan Sunter A; Taşkın U; Berçik İnal B; Sahin M
    J Otolaryngol Head Neck Surg; 2010 Dec; 39(6):744-51. PubMed ID: 21144373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study.
    Linsalata M; Riezzo G; D'Attoma B; Clemente C; Orlando A; Russo F
    BMC Gastroenterol; 2018 Nov; 18(1):167. PubMed ID: 30400824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease.
    Petta S; Marrone O; Torres D; Buttacavoli M; Cammà C; Di Marco V; Licata A; Lo Bue A; Parrinello G; Pinto A; Salvaggio A; Tuttolomondo A; Craxì A; Bonsignore MR
    PLoS One; 2015; 10(12):e0142210. PubMed ID: 26672595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.